Clinical Trials
10 trialsNCT02581137 2026-04-13
Metformin Hydrochloride in Preventing Oral Cancer in Patients With an Oral Premalignant Lesion
National Cancer Institute (NCI)
Phase 2 Active not recruiting
NCT00038727 2021-12-28
DPPOS
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Phase 3 Unknown
NCT02495103 2021-01-26
Vandetanib in Combination With Metformin in People With HLRCC or SDH-Associated Kidney Cancer or Sporadic Papillary Renal Cell Carcinoma
National Institutes of Health Clinical Center (CC)
Phase 1/2 Terminated
NCT01981525 2020-12-14
A Pilot Study of Metformin in Patients With a Diagnosis of Li-Fraumeni Syndrome
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT01312467 2019-03-05
Trial of Metformin for Colorectal Cancer Risk Reduction for History of Colorectal Adenomas and Elevated BMI
National Cancer Institute (NCI)
Phase 2 Completed
NCT01433913 2018-01-10
Metformin Hydrochloride in Treating Patients With Prostate Cancer Undergoing Surgery
National Cancer Institute (NCI)
Phase 2 Completed
NCT01447927 2014-07-21
Metformin Hydrochloride in Preventing Esophageal Cancer in Patients With Barrett Esophagus
National Cancer Institute (NCI)
Phase 2 Completed
NCT00659568 2013-05-30
Metformin and Temsirolimus in Treating Patients With Metastatic or Unresectable Solid Tumor or Lymphoma
National Cancer Institute (NCI)
Phase 1 Completed
NCT00005104 2005-06-24
Randomized Study of Decreased Hyperinsulinemia on the Ovulatory Response to Clomiphene Citrate in Women With Polycystic Ovary Syndrome
National Center for Research Resources (NCRR)
Phase NA Completed
NCT00005654 2005-06-24
Randomized Study of the Effect of Decreased Hyperinsulinemia on the Ovulatory Response to Clomiphene Citrate in Obese Women With Polycystic Ovary Syndrome
Office of Rare Diseases (ORD)
Phase NA Completed